Immunotherapy (PD-1 inhibitor)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Immunotherapy (PD-1 inhibitor), covering 2025-06-29 to 2025-06-29. Get the full timeline:
Most recent: Clinical Trial Update: Standard Chemotherapy vs Immunotherapie in 2nd Line Treatment of MSI Colorectal Mestastatic Cancer [Phase 2]